Page last updated: 2024-08-25

chitosan and Black Fever

chitosan has been researched along with Black Fever in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (84.62)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Covre, LP; de Matos Guedes, HL; Gomes, DCO; Lopes, UG; Ré, MI; Rossi-Bergmann, B; Schwedersky, RP; Souza, BLDSC1
Çetin Uyanikgil, EÖ; Gürbüz Çolak, N; Özbel, Y; Töz, S1
Bora, HK; Chaurasia, M; Chourasia, MK; Dube, A; Gayen, JR; Jaiswal, AK; Meher, JG; Pawar, VK; Raval, K; Singh, PK; Singh, Y; Srikanth, CH1
Chaubey, P; Chaurasia, S; Mishra, B; Monteiro, M; Mudavath, SL; Patel, RR; Sundar, S; Suvarna, V1
Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M1
Chaubey, P; Mishra, B1
Chaubey, P; Mishra, B; Patel, RR1
Asthana, S; Chourasia, MK; Dube, A; Gupta, A; Jain, V; Jaiswal, AK; Pawar, VK1
Asthana, S; Dube, A; Dwivedi, P; Gupta, PK; Jaiswal, AK; Kumar, V; Mishra, PR; Shukla, P; Verma, A1
Bose, PP; Dwivedi, MK; Kumar, P1
Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M1
Chourasia, MK; Dube, A; Dwivedi, AK; Gupta, S; Kunjachan, S1
Asthana, S; Chourasia, MK; Dube, A; Gupta, PK; Jaiswal, AK; Pawar, VK1

Other Studies

13 other study(ies) available for chitosan and Black Fever

ArticleYear
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis.
    Microbes and infection, 2022, Volume: 24, Issue:2

    Topics: Animals; Antigens, Protozoan; Chitosan; Immunity, Cellular; Immunization; Leishmania infantum; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Protozoan Proteins; Vaccination; Vaccines, DNA

2022
The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
    Acta parasitologica, 2022, Volume: 67, Issue:3

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Female; Gels; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Polymers

2022
Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
    International journal of biological macromolecules, 2017, Volume: 105, Issue:Pt 1

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Cricetinae; Cytokines; Drug Carriers; Drug Compounding; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Micelles; Poloxamer; Tissue Distribution

2017
Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
    International journal of biological macromolecules, 2018, Volume: 111

    Topics: Cell Line; Chitosan; Curcumin; Drug Carriers; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles

2018
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1

    Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution

2018
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
    Carbohydrate polymers, 2014, Jan-30, Volume: 101

    Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin

2014
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
    Expert opinion on drug delivery, 2014, Volume: 11, Issue:8

    Topics: Animals; Biological Transport; Chemistry, Pharmaceutical; Chitosan; Curcumin; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Leishmaniasis, Visceral; Male; Mannose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties

2014
Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
    Applied biochemistry and biotechnology, 2014, Volume: 174, Issue:4

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Emulsions; Immunotherapy; Leishmania donovani; Leishmaniasis, Visceral; Lipids; Mice; Nanoparticles

2014
Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Pharmaceutical research, 2015, Volume: 32, Issue:5

    Topics: Alginates; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mesocricetus; Nanoparticles; Rats, Wistar; Stearates

2015
Hemoglobin guided nanocarrier for specific delivery of amphotericin B to Leishmania infected macrophage.
    Acta tropica, 2016, Volume: 158

    Topics: Amphotericin B; Cells, Cultured; Chitosan; Chondroitin Sulfates; Drug Carriers; Hemoglobins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Nanoparticles

2016
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:2

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles

2017
Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis.
    Journal of microencapsulation, 2011, Volume: 28, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Chitosan; Cricetinae; Doxorubicin; Drug Carriers; Drug Evaluation, Preclinical; Leishmaniasis, Visceral; Macrophages; Mesocricetus; Mice

2011
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Cricetinae; Leishmaniasis, Visceral; Male; Nanocapsules

2013